PAX PHARMACEUTICALS (Pvt.) Ltd’s Post

European solidarity and dialogue are essential for securing critical #medicines, Victor Lino Mendonça Mendonça stated in his chat with Citeline Commercial's Generics Bulletin. Find below the full conversation on strengthening Europe’s supply chain and shared industry policy recommendations for our sector. #CriticalMeds #SecurityOfSupply

The pharmaceutical industry in Africa isn’t merely on the peak of growth; it’s poised to explode into a realm of unprecedented opportunities. Imagine a convergence of changing economic profiles, bustling urban centers, surging healthcare spending, and a rising tide of lifestyle-related illnesses—a perfect storm of potential. Join us on March 5th, 2024, for the most electrifying event of the year—the Industry Business Outlook for the Pharmaceutical Industry in Africa. Get ready to be inspired, empowered, and propelled into action as we dive deep into the pulsating heart of Africa’s pharmaceutical renaissance. This isn’t just a conference; it’s a rallying cry, a call to arms for all those who dare to dream big and forge a brighter, healthier future for Africa and beyond. Mark your calendars, spread the word, and be a part of history in the making! @officialcipla AstraZeneca Abbott.nutrition @aurobindopharmaltd Novartis AlphaPharma KSA @specpharmholdings @pharmapcd1 @austellp #AEF #africaeconomicforum #africa #event #pharmaceuticalindustry #businesssoutlook2024 #healthsector

The private sector is critical for reaching AfricanUnion goals for increasing local pharma production in Africa. That’s why Africa CDC, World Health Organization LPA_Worldwide at @WHO, @EU_Partnerships, @BMZ_Bund and @giz_gmbh are bringing together 65+ companies and dozens of stakeholders. #privatepartnerships, #vaccinemanufacturinginAfrica.

🌐🏥🔍📦 A great article on the challenges Europe faces from a #CriticalMedicines perspective #AfforableMedicines 🌡️🚑💊🌍🇪🇺

AMR (Anti-Microbial Resistance) is a huge public health issue. With almost 1M deaths in India alone in 2019, UN estimates 10M deaths globally by 2050 – the same number as cancer. Much like ‘Swachhhta’, AMR is everyone's problem, and therefore no one’s. Addressing the community aspects of AMR (self-medication, sale without Rx, antibiotics in food, etc.) needs a concerted effort, one involving the Government, NGOs, regulation, community. One hopes for a movement, an ‘abhiyaan’. At Orchid, we believe that even as we wait for this abhiyaan, the pharma and healthcare community can collectively make a significant effort towards breaking the vicious cycle of AMR. It is possible for all of us to be commercially viable, while being ethical, and doing what is right for society. This means working towards reducing (yes, REDUCING) antibiotic consumption, and particularly that of the "reserve drugs". Orchid’s mission is to help hospitals reduce HAI (Hospital Acquired Infections) and AMR, thereby reducing the average length of stay (ALOS) of patients. The tangible and intangible benefits of that would offset the financial impact of controlled consumption of antibiotics. I spoke with NDTV earlier this week about some of the solutions that Orchid has put-together to address AMR. I do believe that, when one sets out with the right intent, the universe aligns and leads to success. Let's be the change we want to see.

Catch up on the key insights from Session 2 at #ISPOR_Saudi24! Watch the promo of the speakers discussing “Contracting and Market Access Strategies for Orphan Drugs”

The PharmaConnect Africa Conference 2024 kicked off with a powerful opening address by Mr. Keegan Mwape, President of the Pharmaceutical Society of Zambia. The conference aims to tackle the critical issue of market access in Africa, exploring innovative solutions and collaborations to improve access to quality medicines and healthcare services. Mr. Mwape emphasized the significance of the conference theme, "Market Access in Africa—What are the Catalysts for Change," highlighting the opportunities for meaningful change in the face of regulatory complexities, supply chain inefficiencies, and economic disparities. He outlined the key catalysts for change including; #Innovation_*: Harnessing digital health, pharmaceutical advancements, and new technologies to transform healthcare delivery. #Regulatory_Harmonization_*: Streamlining processes to ensure life-saving medicines reach patients quickly and efficiently. #Public_Private_Partnerships_*: Collaborating to pool resources, share expertise, and scale up solutions. #Capacity_Building:* Investing in education, training, and infrastructure development to meet future demands. Mr. Mwape urged attendees to engage actively in discussions, share insights, and collaborate on actionable strategies to create a future where all Africans have access to high standards of healthcare. For a deeper dive into the President's vision and call to action, please find the attached full speech. #Media& #CorporateAffairs #Committe #Pharmaceutical_Society_of_Zambia

Please see our efforts to support patient needs through Europe Critical Medicines Alliance launch with our EU president Artur Cwiok representing Viatris in this very important alliance. At Viatris we are #1Billion patients proud and this partnership and alliance is another stepping stone on how we walk the talk on our commitment to patients. #CriticalMedicinesAlliance; #AccessAtScale; #ViatrisEurope

Very interesting the article to learn more about the clinical trial landscape in Africa and what Sanofi is doing to break down barriers and create a more diverse and equitable future. https://lnkd.in/ePMUC3yF

Wonder why access to medicines matters and is still a relevant topic in Europe?  In my latest op-ed shared with Euractiv, discover how Viatris is contributing to support patients’ needs, as I had the pleasure to represent my company at the Europe’s Critical Medicines Alliance launch in Brussels - with Medicines for Europe Read the op-ed here: https://bit.ly/44i1Ces Credentials for picture Belgian Presidency of the Council of European Union #CriticalMedicinesAlliance; #AccessAtScale; #ViatrisEurope